Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
Yongjun Wanga b c d e, Yongjun Wanga b c d e f✉, S. Claiborne Johnstonf g, Philip M. Bathg h, James C. Grottaa b c e h, Yuesong Pana b c e i, Pierre Amarencoa b c e i, Yilong Wanga b c d e j k l✉, Yilong Wanga b c d e m, Tabassome Simonj k l n, Jong Sung Kima b c e m, Jiann‐Shing Jengn o, Liping Liua b c e p, Yi Lino q r, Ka Sing Wonga b c e p, David Wangq r, Hao Lia b c e
- aBeijing Key Laboratory of Translational Medicine for Cerebrovascular Disease, Beijing, China
- bCenter of Stroke, Beijing Institute for Brain Disorders, Beijing, China
- cChina National Clinical Research Center for Neurological Diseases, Beijing, China
- dDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China yongjunwang@ncrcnd.org.cn
- eDepartment of Neurology, Beijing Tiantan Hospital, Capital Medical University, Beijing, China
- fDean's Office, Dell Medical School, University of Texas at Austin, Austin, TX, USA
- gStroke Trials Unit, Division of Clinical Neuroscience, University of Nottingham, Nottingham, UK
- hClinical Innovation and Research Institute, Memorial Hermann Hospital, Houston, TX, USA
- iDepartment of Neurology and Stroke Center, Bichat University Hospital and Paris-Diderot, Sorbonne University, Paris, France
- jDepartment of Clinical Pharmacology and Clinical Research Platform of East of Paris, Assistance Publique-Hôpitaux de Paris, Paris, France
Papers open inside SciRah from the original publisher or repository; SciRah never hosts them.
Abstract
Yongjun Wang and colleagues discuss recent evidence for using dual antiplatelet therapy to reduce recurrence of stroke or transient ischaemic attack
TL;DRYongjun Wang and colleagues discuss recent evidence for using dual antiplatelet therapy to reduce recurrence of stroke or transient ischaemic attack. (Semantic Scholar)